Health Guide

Omeprazole vs Pantoprazole: Which PPI Is Better?

Omeprazole (Prilosec) and pantoprazole (Protonix) are two of the most prescribed PPIs. Both suppress stomach acid effectively, but they differ in drug interactions and cost. Here is how to choose.

By James Okafor, RPh, MBA
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Published June 21, 2026
Last reviewed June 15, 2026
3 min read

The Quick Answer

Omeprazole and pantoprazole are both highly effective PPIs with similar acid suppression and clinical outcomes. Pantoprazole has fewer drug interactions (particularly with clopidogrel) and is preferred in hospital settings. Omeprazole is available over the counter and is often cheaper. For most patients with GERD, either drug is an excellent choice.

Side-by-Side Comparison

FeatureOmeprazole (Prilosec)Pantoprazole (Protonix)
Brand namePrilosecProtonix
OTC availableYes (20 mg)No (Rx only)
Generic cost (Rx)$4–$15/month$10–$20/month
OTC cost$15–$25 (42 tablets)N/A
Acid suppression~97% inhibition at 20 mg~95% inhibition at 40 mg
CYP2C19 interactionStrong inhibitorWeak inhibitor
Clopidogrel interactionReduces clopidogrel efficacyMinimal interaction
IV formulationAvailableAvailable (preferred in hospitals)
Typical dose20–40 mg once daily40 mg once daily
FDA approval year19892000

The Clopidogrel Interaction: A Critical Difference

Clopidogrel (Plavix) is an antiplatelet drug used after heart attack, stent placement, and stroke. It is a prodrug that requires activation by CYP2C19 in the liver. Omeprazole is a strong CYP2C19 inhibitor — it reduces the conversion of clopidogrel to its active form, potentially reducing its antiplatelet effect by 40–50%.

The FDA issued a safety communication in 2010 warning against the combined use of clopidogrel and omeprazole. Pantoprazole is a much weaker CYP2C19 inhibitor and does not significantly reduce clopidogrel efficacy. For patients on clopidogrel who need a PPI (e.g., for GI protection), pantoprazole is the preferred choice.

Efficacy: Are They Equally Effective?

Multiple head-to-head trials and meta-analyses have found that omeprazole and pantoprazole provide similar rates of symptom relief and healing of erosive esophagitis. A 2009 meta-analysis of 12 trials found no significant difference in GERD symptom relief between the two drugs. Both achieve >95% inhibition of gastric acid secretion at standard doses.

Omeprazole may have slightly faster onset of action due to its higher bioavailability, but this difference is not clinically meaningful for most patients.

Drug Interactions: Pantoprazole Has Fewer

All PPIs are metabolized by CYP2C19 and CYP3A4, but to different degrees. Omeprazole is the strongest CYP2C19 inhibitor among PPIs, while pantoprazole has the weakest CYP2C19 inhibitory effect. This matters for:

  • Clopidogrel — Use pantoprazole (or rabeprazole) instead of omeprazole
  • Methotrexate — PPIs (especially omeprazole) can increase methotrexate levels; monitor
  • Tacrolimus — Omeprazole increases tacrolimus levels more than pantoprazole
  • Warfarin — All PPIs can slightly increase INR; monitor with omeprazole

When to Choose Pantoprazole

  • Patient is on clopidogrel (Plavix)
  • Patient is on multiple medications metabolized by CYP2C19
  • Hospital inpatient (pantoprazole IV is the standard in most hospitals)
  • Insurance covers pantoprazole at lower cost than omeprazole

When to Choose Omeprazole

  • OTC treatment preferred (no prescription needed)
  • Cost is a priority (often cheaper as generic or OTC)
  • No significant drug interactions present
  • Patient prefers a drug with the longest track record

Cost Comparison

Omeprazole is available OTC at $15–$25 for a 42-day supply (20 mg). Generic prescription omeprazole costs $4–$15/month. Generic pantoprazole costs $10–$20/month. With a discount card, both are available for under $15/month at most pharmacies. See our omeprazole cost guide and pantoprazole cost guide for current pricing.

References

  1. Focks JJ, et al. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome. Eur Heart J. 2013;34(23):1744-1753.
  2. Gralnek IM, et al. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol. 2006;4(12):1452-1458.
  3. FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. 2012.

Save up to 80% on this medication

Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.

Get Discount
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. Read our full disclaimer.

About the Author

James Okafor, RPh, MBA

Registered Pharmacist & Health Economics Writer

James Okafor is a registered pharmacist with over 12 years of experience in retail and clinical pharmacy settings. He holds an MBA with a focus on healthcare management and specializes in translating complex drug pricing, formulary, and insurance coverage topics into clear, actionable guidance for patients. Before joining RxGuide, James worked as a clinical pharmacist at a regional hospital system and as a pharmacy benefits consultant for a national PBM. His writing focuses on cost transparency, generic alternatives, and helping patients navigate the U.S. prescription drug system.

View full profile on our Editorial Team page →

Get the RxGo app — free prescription discounts on the go

Works at 67,000+ pharmacies · No membership needed

Download